Taken together, inhibiting PD-1/PD-L1 signaling restored the enteric microbiota dysbiosis in mice with colitis by enriching the abundance of SCFA-producing bacteria as well as mucosal immune-related bacteria. This evidence concerns the gene CD274 and colitis.